A Food-drug Interaction Study of SY-004 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2021

Primary Completion Date

October 11, 2021

Study Completion Date

October 11, 2021

Conditions
Type 2 Diabetes
Interventions
DRUG

SY-004 capsule

After fasting for 10 hours, subjects in group 1 took one SY-004 (80mg) orally on an empty stomach on the day of administration with 240ml warm water; Subjects in group 2 began to eat high-fat breakfast 30 minutes before administration , and took one SY-004 capsule(80mg) orally with 240ml warm water. The subjects in both groups were fasted within 4 hours after taking the medicine, and drinking water was forbidden within 1 hour before and after taking SY-004.

Trial Locations (1)

241000

XIE Haitang, Wuhu

All Listed Sponsors
lead

Suzhou Yabao Pharmaceutical R&D Co., Ltd.

INDUSTRY

NCT04907006 - A Food-drug Interaction Study of SY-004 in Healthy Subjects | Biotech Hunter | Biotech Hunter